Learn more

I MAB

Overview
  • Total Patents
    80
  • GoodIP Patent Rank
    18,141
  • Filing trend
    ⇩ 22.0%
About

I MAB has a total of 80 patent applications. It decreased the IP activity by 22.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are R S R LTD, KIRA BIOTECH PTY LTD and ADAERATA LTD PARTNERSHIP.

Patent filings per year

Chart showing I MABs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Fang Lei 70
#2 Guo Bingshi 67
#3 Wang Zhengyi 67
#4 Zang Jingwu 63
#5 Wang Yongqiang 14
#6 Jiang Wenqing 10
#7 Zhengyi Wang 7
#8 Jingwu Zang 7
#9 Bingshi Guo 7
#10 Lei Fang 7

Latest patents

Publication Filing date Title
WO2020038397A1 Anti-pd-l1/anti-lag3 bispecific antibodies and uses thereof
CN110678484A anti-PD-L1/anti-LAG 3 bispecific antibodies and uses thereof
WO2019185029A1 Anti-pd-l1 antibodies and uses thereof
CN110352200A The antibody of the anti-T cell immunity receptor (TIGIT) with Ig and ITIM structural domain and its application
US2021095019A1 Fusion Proteins Containing CD47 Antibodies and Cytokines
KR20190111894A Anti-lag-3 antibodies and uses thereof
KR20190105122A Anti-cd73 antibodies and uses thereof
BR112019008010A2 isolated monoclonal antibody or immunologically active fragment thereof, isolated bispecific monoclonal antibody, pharmaceutical composition, method for treating a disease in a human subject in need thereof, fusion protein, cd47 gene encoded immunodominant epitope, and biological molecule
MX2018015584A Anti-pd-l1 antibodies and uses thereof.
WO2018152687A1 Anti-lymphocyte activation gene-3 (lag-3) antibodies and uses thereof